Skip to main content
Article
Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: a Brown University Oncology Group Phase II Study.
American Journal of Clinical Oncology (2015)
  • Howard Safran, Brown University
  • Kevin P. Charpentier, Brown University
  • Andreas Kaubisch, Yeshiva University
  • Kalyan Mantripragada, Brown University
  • Gregory Dubel
  • Kimberly Perez, Brown University
  • Katherine Faricy-Anderson
  • Thomas Miner, Brown University
  • Yoko Eng, Yeshiva University
  • Joel Victor, Yeshiva University
  • Angela Plette, Brown University
  • Joseph Espat
  • Pamela Bakalarski
  • Patti Wingate
  • David Berz, Brown University
  • Denise Luppe, Brown University
  • Diane Martel
  • Kayla Rosati, Brown University
  • Santiago Aparo, Yeshiva University
Publication Date
January 2, 2015
DOI
10.1097/COC.0b013e3182868c66
Citation Information
Howard Safran, Kevin P. Charpentier, Andreas Kaubisch, Kalyan Mantripragada, et al.. "Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: a Brown University Oncology Group Phase II Study." American Journal of Clinical Oncology Vol. 38 Iss. 1 (2015) p. 1 - 4
Available at: http://works.bepress.com/santiago-aparo/5/